Christopher M.Lomax (Chris)

Associate

Miami + 1.305.714.9719

Connect:

Share

Chris Lomax is an experienced litigator and trial lawyer with significant experience in civil and criminal litigation. He has represented clients across many industries in litigation involving contract disputes, business torts, misappropriation of trade secrets, fraud, and other complex commercial and criminal matters. He has served as a first-chair trial lawyer in federal and state courts around the country and has handled appeals on the state and federal levels. Chris has also advised clients in connection with responding to federal and state attorneys general investigations.

Prior to joining Jones Day, Chris was a federal prosecutor with the U.S. Department of Justice (DOJ) where he primarily focused on human trafficking, hate crimes, and law enforcement misconduct cases. During his time with the DOJ, he conducted numerous grand jury investigations and successfully prosecuted cases in federal courts throughout the country. He worked closely with the Federal Bureau of Investigation, Department of Homeland Security, U.S. Treasury Inspector General for Tax Administration, and a variety of other federal and state agencies. While at the DOJ, Chris received two Special Commendations for Outstanding Service and a Special Achievement Award.

In addition to his extensive litigation experience, Chris currently serves on the teaching faculty for Harvard Law School's Trial Advocacy Workshop and has served as a faculty member for the National Institute of Trial Advocacy.

Experience

  • Universities defend multidistrict putative class action litigation brought by former football playersJones Day is serving as lead counsel for all NCAA member institution defendants in a multidistrict litigation ("MDL") consolidating more than 500 putative class actions brought on behalf of former football players.
  • Chevron buys Pasadena Refining System for $350 million from Petrobras America Inc.Jones Day advised Chevron U.S.A. Inc., a wholly-owned subsidiary of Chevron Corporation, in its purchase of all of the equity interests of Pasadena Refining System Inc. ("PRSI") and PRSI Trading, LLC from Petrobras America Inc. for $350 million, subject to adjustments for working capital.
  • University system conducts internal investigation into allegations of sexual assaultJones Day has been retained by a university system to conduct an independent investigation relating to allegations of sexual assault, as well as to assist the university in its responses to threatened litigation.
  • Investors resolve dispute with claimed inventor of low energy nuclear reaction deviceJones Day represented an investment company, two alternative energy technology companies, and two executives in connection with litigation brought by Andrea Rossi and Leonardo Corporation.
  • ResMed successfully resolves antitrust litigation brought by competitorJones Day represented ResMed Corp. in connection with antitrust litigation brought by 3B Medical, Inc. alleging monopolization and exclusive dealing.
  • Crédito Real acquires 65 percent of AFS Acceptance to scale up its used car business in the U.S.Jones Day advised Crédito Real, S.A.B de C.V., SOFOM, E.R. ("Crédito Real") in its acquisition of 65 percent of the equity interests issued by AFS Acceptance LLC, a financial institution focused on granting loans for the acquisition of used cars in the U.S.
  • Major multinational corporation undergoes internal investigation into accounting fraud and corruptionJones Day conducted an internal investigation into alleged accounting fraud and corruption in the international operations of a major publicly traded multinational corporation.
    • View All
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.